https://adisinsight.springer.com/drugs/800057681?error=cookies_not_supported&code=f4131f96-ad96-4206-b20d-4c81c07d430b
CLX GI 62D2 - AdisInsight
CLX GI 62D2 is being developed by Cellix Bio, for the treatment of faecal incontinence. Preclinical development is underway in India.
clxgiadisinsight